New Immunotherapy Shows Promise in Fighting Metastatic Breast Cancer
Related Posts
FDA Approves Skyrizi for Moderately to Severely Active Crohn Disease
MONDAY, June 20, 2022 (HealthDay News) -- Skyrizi (risankizumab-rzaa), an...
Early-Onset Cancer Morbidity Continuing to Increase
THURSDAY, Sept. 7, 2023 (HealthDay News) -- Early-onset cancer morbidity is...
Reguladores europeos investigan el riesgo de ideación suicida con unos populares fármacos para perder peso
MARTES, 11 de julio de 2023 (HealthDay News) -- La Agencia Europea de...
Statement Outlines Inequities in Cardio-Oncology Care, Research
THURSDAY, July 6, 2023 (HealthDay News) -- Inequities in cardio-oncology care...